Therefore, it is credible that resveratrol can dose-dependently curb CRC cell growth and migration by increasing the expression of potential p21 while decreasing the expression of cyclin D1 in HCT116 WT but not in HCT-116 p53-/- cells. This evidence concerns the gene CCND1 and colorectal carcinoma.